Marktgröße und Marktanteil von Medikamenten gegen neurologische Störungen bis 2025 – 2031
Neurological Disorder Drugs Market Report Analysis
Neurological Disorder Drugs Market
-
CAGR (2023 - 2031)XX% -
Market Size 2023
US$ XX million -
Market Size 2031
US$ XX Million
Report Coverage
- Market size and forecast at global, regional, and country levels for all the key market segments covered under the scope
- Key future trends
- Detailed PEST/Porter’s Five Forces and SWOT analysis
- Industry landscape and competition analysis & recent developments
- Detailed company profiles
- Global and regional market analysis covering key market trends, major players, regulations, and recent market developments
Key Players
- Neurocrine Biosciences, Inc.,
- Pfizer Inc.,
- Biogen Inc.,
- Teva Pharmaceutical Industries Ltd.,
- AcelRx Pharmaceuticals, Inc.,
- Eli Lilly and Company,
- Adamas Pharmaceuticals, Inc.,
- BioMarin Pharmaceutical Inc
- AstraZeneca plc,
Regional Overview
- Nordamerika
- Europa
- Asien-Pazifik
- Süd- und Mittelamerika
- Naher Osten und Afrika
Market Segmentation
By Arzneimitteltyp
- Antipsychotikum
- Antiepileptikum
- Anticholinergikum
- Analgetika
- Hypnotikum und Beruhigungsmittel
- Antikoagulanzien
- Antihypertensivum
By Krankheitstyp
- Epilepsie
- Parkinson-Krankheit
- Alzheimer-Krankheit
- zerebrovaskuläre Erkrankung
- Multiple Sklerose
By Vertriebskanal
- Krankenhausapotheken
- Einzelhandelsapotheken
- Online-Apotheken.
By Geographie
- Nordamerika
- Europa
- Asien-Pazifik
- Süd- und Mittelamerika
Get Free Sample For